New Edge Advisors, LLC Biovie Inc. Transaction History

New Edge Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$1.22 - $5.24 $61 - $262	50 Added 5.26%	1,000 $1,000
Q3 2023 Nov 14, 2023	BUY	$2.75 - $5.17 $2,062 - $3,877	750 Added 375.0%	950 $3,000
Q1 2023 May 12, 2023	BUY	$4.89 - $10.53 $488 - $1,053	100 Added 100.0%	200 $1,000
Q4 2022 Feb 14, 2023	BUY	$3.86 - $42.0 $386 - $4,200	100 New	100 $0

340K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $68.5M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.